Haba Laboratories

Haba Laboratories AAQS

The The AAQS of Haba Laboratories (4925.T) as of Oct 20, 2026 is 1. In the previous year, The AAQS was 1.00 — a change of 0.00% (lower).

AAQS

1

YoY

0.00%

Last updated:

Haba Laboratories has a current AAQS of 1.

A high AAQS can be seen as a positive indicator that the company is developing successfully.

Investors can assume that the company is on a good path to generate profits.

On the other hand, it is important to consider the AAQS of the stock Haba Laboratories in comparison to the profits generated and other companies in the same industry. A high AAQS is not an absolute guarantee for a positive future. Only in this way can one get a complete picture of the company's performance.

In order to better assess the company's development, it is important to consider the AAQS in comparison to other companies in the same industry. In general, investors should always consider the AAQS of a company in connection with other fundamentals such as profit, EBIT, cash flow, and others in order to make an informed investment decision.

The Haba Laboratories AAQS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

AAQS
Date
AAQS
Jan 1, 2019
1.00 JPY
Jan 1, 2020
1.00 JPY
Jan 1, 2021
1.00 JPY
Jan 1, 2022
1.00 JPY
Jan 1, 2023
1.00 JPY
Jan 1, 2024
1.00 JPY
Jan 1, 2025
1.00 JPY
Jan 1, 2026
1.00 JPY
The Haba Laboratories AAQS history
YEARAAQSYoY
10.00%
10.00%
10.00%
10.00%
10.00%
10.00%
10.00%
10.00%
10.00%
10.00%
10.00%
10.00%
1—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Haba Laboratories Stock analysis

What does Haba Laboratories do? HABA Laboratories, Inc. generates revenue through the development, manufacture, and sale of natural cosmetics, quasi-drugs, and nutritional supplements. The company distributes its products via wholesale to department stores and through mail order services to general customers, while also selling directly at its own retail stores. Its main business focuses on women's and men's cosmetics, targeting consumers seeking natural beauty and health solutions through both retail and direct channels. The firm's revenue streams include wholesale distribution to retailers and wholesalers, alongside direct sales at its retail stores. Products are marketed under the HABA brand, with a focus on natural ingredients for cosmetics, quasi-drugs, and nutritional supplements. The company serves both individual consumers through mail order and business clients through wholesale partnerships. HABA Laboratories' business model relies on a dual approach of B2B and B2C sales, with department stores, retailers, and wholesalers as key wholesale partners. The company's product portfolio caters to the growing demand for natural personal care items, leveraging its retail presence and mail order services to reach a broad customer base. Haba Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Haba Laboratories stock

The AAQS of Haba Laboratories is 1 in 2026.

On Eulerpool you can find the complete historical development of The AAQS Haba Laboratories since 2006 – with annual values, charts, and detailed analysis.

The AAQS is a key figure developed by AlleAktien.

The AAQS is a key figure developed by AlleAktien.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quality — Haba Laboratories

All Key Metrics — Haba Laboratories